Description
Peptide Composition
GLOW 70 mg is composed of the following peptide blend:
BPC-157 – 10 mg
TB-500 (Thymosin Beta-4 fragment) – 10 mg
GHK-Cu (Copper Peptide) – 50 mg
This formulation enables the investigation of multiple biological pathways within a single experimental framework, particularly in studies involving cellular communication and matrix-related processes.
Biochemical Characteristics
All peptides within the GLOW complex are synthesized using advanced solid-phase peptide synthesis (SPPS) techniques and purified through high-performance liquid chromatography (HPLC), with analytical verification via mass spectrometry.
Form: Lyophilized powder
Total Content: 70 mg per vial
Purity: ≥ 99% (analytical standard)
Manufacturing: Controlled laboratory environment
High-purity peptide compounds are essential for minimizing variability and ensuring reproducibility in controlled research settings.
Research Context
Peptides included in the GLOW formulation are commonly studied in experimental models involving:
Cellular signaling and communication pathways
Extracellular matrix and tissue-related mechanisms
Peptide-receptor interaction dynamics
Biomolecular and structural protein research
In-vitro and preclinical experimental systems
The combination of peptides allows for broader pathway exploration and analysis of potential synergistic interactions within controlled laboratory conditions.
Form & Stability
GLOW is supplied in lyophilized form to enhance stability during storage and transport. Lyophilization preserves structural integrity by removing moisture under controlled conditions.
Storage guidelines:
Store in a cool, dry place
Protect from light exposure
Refrigeration recommended after reconstitution
Disclaimer
This product is intended for laboratory research purposes only.
Not for human consumption, medical, diagnostic, or therapeutic use.
All information provided is for scientific and educational purposes only.






Reviews
There are no reviews yet.